ClinicalTrials.Veeva

Menu

Laparoscopic Versus Open Surgery for Lesions Originating in the Paracaval Portion of the Caudate Lobe

A

Army Medical University

Status

Unknown

Conditions

Paracaval Portion

Treatments

Procedure: laparoscopic surgery
Procedure: Open surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT04499261
SWHZSG010

Details and patient eligibility

About

This study aimed to evaluate the safety, feasibility and efficacy of laparoscopic for resecting paracaval-originating lesions by contrast of open procedures.

Full description

The paracaval portion of the caudate lobe is located in the core of the liver. Lesions originating in the paracaval portion often cling to or even invade major hepatic vascular structures. Open surgery is the traditional surgical method for resection of paracaval-originating lesions. With the development of laparoscopic surgery, paracaval-originating lesions are no longer an absolute contraindication for laparoscopic procedures. The high-definition magnified view and ability to change perspectives with the laparoscope are conducive to subtle manipulation, and compression of the carbon dioxide pneumoperitoneum can reduce venous bleeding. Nevertheless, laparoscopic anterior hepatic transection for paracaval-originating lesion resection is still a challenging procedure, and only a few cases have been reported. This study aimed to evaluate the safety, feasibility and efficacy of laparoscopic for resecting paracaval-originating lesions by contrast of open procedures.

Enrollment

110 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age: Between 18 to 70 years, both male and female
  2. The general condition of the patient can tolerate anesthesia and surgery
  3. Paracaval-originating lesion diagnosis is clear preoperative
  4. No rupture of the tumor, no bloody ascites, no invasion of the surrounding tissues and distant metastasis
  5. Liver function ≥ Child-pugh level B, indocyanine green retention rate at 15 min ≤ 15%, the residual liver volume and standard liver volume ratio ≥ 40%.
  6. Upper abdominal surgery, radiofrequency ablation, Transhepatic Arterial Chemotherapy And Embolization treatment, radiotherapy and chemotherapy have not been implemented
  7. Volunteer to participate in the study and sign informed consent

Exclusion criteria

  1. Age:Younger than 18 or more than 70 years old 2. Pregnant and lactating women 3. Severe cirrhosis, portal hypertension, or active hepatitis are present 4. Severe upper abdominal adhesions 5. The lesion originated in other parts of the liver other than the paracaval portion 6. Patients with poor general condition and could not tolerate surgery or anesthesia

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

110 participants in 2 patient groups

laparoscopic surgery
Experimental group
Description:
The laparoscopic view is caudal to cephalic, which is consistent with the direction of hepatic transection. In addition, the high-definition magnified view and ability to change perspectives with the laparoscope are conducive to subtle manipulation, and compression of the carbon dioxide pneumoperitoneum can reduce venous bleeding. Therefore, laparoscopic surgery may have certain advantages in the treatment of paracaval-originating lesions.
Treatment:
Procedure: laparoscopic surgery
Open surgery
Active Comparator group
Description:
Open surgery is the traditional surgical method for resection of paracaval-originating lesions.
Treatment:
Procedure: Open surgery

Trial contacts and locations

1

Loading...

Central trial contact

Shuguo Zheng, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems